DCGI Grants Conditional Market Approval For Covishield and Covaxin
India.com News Desk | Jan 27, 2022, 3:18 PM IST
Drugs Controller General of India (DCGI) grants conditional market approval for Covishield and Covaxin.
India.com News Desk | Jan 27, 2022, 3:18 PM IST
Drugs Controller General of India (DCGI) grants conditional market approval for Covishield and Covaxin.
India.com News Desk | Jan 26, 2022, 5:59 PM IST
The National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable.
India.com News Desk | Jan 14, 2022, 7:16 AM IST
The Drugs Controller General of India (DCGI) on Friday will review applications filed by Bharat Biotech and Serum Institute of India for full market approval of its respective COVID vaccines - Covaxin and Covishield, sources said.
India.com News Desk | Dec 1, 2021, 9:30 PM IST
Recently, Kerala, Rajasthan, Karnataka and Chhattisgarh have urged the Centre to decide on allowing booster doses of Covid-19 vaccine diseased amid concerns raised by 'Omicron', the new variant of SARS-CoV-2.
India.com News Desk | Oct 27, 2021, 5:33 PM IST
An experts' committee has been set by the Kerala Adventure Tourism Promotion Society (KATPS), which functions under the Department of Tourism, to prepare safety parameters for the Adventure Tourism sector.
India.com News Desk | Oct 26, 2021, 5:01 PM IST
Bharat Biotech had submitted the Expression of Interest (EOI) for the emergency use approval in April, but WHO has said it needs more data from the company.
India.com News Desk | Oct 5, 2021, 8:40 PM IST
Developed by Bharat Biotech in partnership with the National Institute of Virology and ICMR, Covaxin displayed an efficacy of nearly 78 per cent in clinical trials.
PTI | Jul 6, 2021, 9:36 PM IST
The Centre is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.
India.com News Desk | Jun 4, 2021, 9:26 PM IST
According to the four conditions set by the DCGI, the Serum Institute will have to submit a copy of the agreement between it and the Gamaleya Research Institute of Epidemiology and Microbiology for transfer of cell bank and virus stock and submit the copy of agreement for technology transfer with Gamaleya.
India.com News Desk | Jun 2, 2021, 6:34 PM IST
The complete data on the Central Government's purchase history of all the COVID-19 vaccines till date (Covaxin, Covishield and Sputnik V).